In a research report issued yesterday, Oppenheimer analyst Akiva Felt reiterated an Outperform rating on shares of Zogenix, Inc. (NASDAQ:ZGNX) with a price target …
Oppenheimer analyst Akiva Felt weighed in with a few insights on Amarin Corporation plc (ADR)(NASDAQ:AMRN), after the pharmaceutical company released its second-quarter results last week. …
Oppenheimer analyst Akiva Felt offered some commentary on Intercept Pharmaceuticals Inc (NASDAQ:ICPT) following the announcement that it has completed its NDA filing for obeticholic acid …
Oppenheimer’s healthcare analyst Akiva Felt reiterated an Outperform rating on Zogenix, Inc. (NASDAQ:ZGNX) with a $2.
Dyax Corp. (NASDAQ:DYAX) shares are up 47% today after the company announced positive data from the Phase 1b clinical study of its investigational product, DX-2930, which is being developed …
Oppenheimer analyst Akiva Felt came out with his views on Amarin Corporation plc (ADR) (NASDAQ:AMRN), after the company reported its fourth-quarter financial results. The company reported quarterly …
In a research report sent to investors, Oppenheimer analyst Akiva Felt reiterated an Outperform rating on Intercept Pharmaceuticals (NASDAQ:ICPT) with a price target …
Oppenheimer analyst Akiva Felt maintained an Outperform rating on Neuroderm (NASDAQ:NDRM) and slightly raised his price target to $19 (from $18), which implies …
Oppenheimer analyst Akiva Felt joined the crowd today, reiterating an Outperform rating on Cubist Pharmaceuticals (NASDAQ:CBST) while also, surprisingly, keeping his price target at $83, as multiple news outlets reported …
In a research report issued today, Oppenheimer analyst Akiva Felt reiterated an Outperform rating on Mallinckrodt (NYSE:MNK) with a $111 price target, which …
